undamentalytics Newsletter

Mannkind Corp key statistics and ratios

In fiscal 2025, Mannkind Corp had an operating margin of 11.1% and a current ratio of 1.70. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Mannkind Corp: financial ratios, annual
Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Gross margin——————90.2%−46.7%30.4%68.1%76.8%77.7%84.0%89.5%93.9%92.3%89.8%
Operating margin<−999%<−999%<−999%———38.5%−921.1%−274.9%−70.7%−73.5%−62.3%−64.3%4.4%25.4%11.1%2.3%
Net margin<−999%<−999%<−999%———71.9%−999.0%−312.2%−82.3%−87.9%−107.3%−87.6%−6.0%9.7%1.7%−11.1%
Free-cash-flow margin<−999%<−999%<−999%———−45.3%—−136.7%−144.4%−44.4%−97.0%−88.5%−4.2%11.5%3.9%−4.6%
Return on assets−61.5%−67.5%−75.1%−75.1%−60.8%−141.5%107.6%−122.5%−90.5%−51.5%−56.6%−37.7%−28.4%−3.1%6.3%1.0%−5.7%
Asset turnover0.000.000.00———1.500.120.290.630.640.350.320.520.660.590.52
Current ratio4.080.230.460.600.500.290.840.651.090.931.084.543.493.593.281.701.72
Interest cover (operating income ÷ interest)n/mn/mn/mn/mn/mn/m4.3xn/mn/mn/mn/mn/mn/m0.6x6.1x2.8x0.3x
Effective tax rate——————0.0%———————9.6%——
R&D as % of revenue>999%>999%>999%———8.5%120.2%31.4%10.9%9.6%16.3%19.8%15.7%16.1%19.0%19.5%
SG&A as % of revenue——————26.9%638.2%286.1%118.5%90.6%102.6%91.7%47.4%33.0%41.3%50.8%
Capital spending as % of revenue>999%>999%>999%———0.7%—1.3%4.1%1.2%15.2%7.6%21.3%3.4%1.3%2.6%
Free cash flow ÷ net income——————−63.1%———————119.0%233.5%—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

1 of 5 checks passed · June 30, 2026
What it owns · $732m
Short-term assets $246mLonger-term assets $487m
What it owes, and who funded it · $800m
Short-term liabilities $143mLonger-term liabilities $657mShareholders' equity $-67m
  • Short-term assets cover short-term liabilities $246m of assets due within a year against $143m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $246m short-term assets against $657m of longer-dated liabilities.
  • More cash than debt $53m of cash against $319m of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$8m of operating cash flow against $319m of debt.
  • Operating profit covers interest at least five times over Operating income of $9m against $28m of interest.

From Mannkind Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

20 /100

Weak moat

How hard Mannkind's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -12.7% of total assets over 7 years.

  • Pricing power 12 / 20

    Gross margin has been a median 78.6%, moving by 37.7 percentage points (standard deviation) across 9 years.

  • Durability 10 / 20

    Operating margin has been a median -36.8%; its worst year was -749.0%.

  • Cash conversion 2 / 20

    Free cash flow was positive in 2 of 9 years, at a median -55.0% of revenue.

  • Discipline 1 / 20

    The diluted share count rose 29.3% over five years; stock-based pay has been a median 9.6% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (25 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: MGTX vs MNKDMNKD vs SVAMNKD vs PHARMNKD vs NVAX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Mannkind Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mannkind Corp.